181 related articles for article (PubMed ID: 36174850)
1. Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers.
Berg S; Edlund H; R F Goundry W; A S Bergström C; Davies NM
Int J Pharm; 2022 Nov; 628():122238. PubMed ID: 36174850
[TBL] [Abstract][Full Text] [Related]
2. Evaluation in pig of an intestinal administration device for oral peptide delivery.
Berg S; Uggla T; Antonsson M; Nunes SF; Englund M; Rosengren L; Fahraj M; Wu X; Govender R; Söderberg M; Janzén D; Van Zuydam N; Hugerth A; Larsson A; Abrahmsén-Alami S; Abrahamsson B; Davies N; Bergström CAS
J Control Release; 2023 Jan; 353():792-801. PubMed ID: 36493948
[TBL] [Abstract][Full Text] [Related]
3. Progress and limitations of oral peptide delivery as a potentially transformative therapy.
Tran H; ElSayed MEH
Expert Opin Drug Deliv; 2022 Feb; 19(2):163-178. PubMed ID: 35255753
[TBL] [Abstract][Full Text] [Related]
4. Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans.
Maher S; Geoghegan C; Brayden DJ
Expert Opin Drug Deliv; 2021 Feb; 18(2):273-300. PubMed ID: 32937089
[TBL] [Abstract][Full Text] [Related]
5. Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.
Richard J
Ther Deliv; 2017 Jul; 8(8):663-684. PubMed ID: 28730934
[TBL] [Abstract][Full Text] [Related]
6. Oral peptide delivery: Translational challenges due to physiological effects.
Tyagi P; Pechenov S; Anand Subramony J
J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
[TBL] [Abstract][Full Text] [Related]
8. Intestinal permeation enhancers for oral peptide delivery.
Maher S; Mrsny RJ; Brayden DJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
[TBL] [Abstract][Full Text] [Related]
9. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
[TBL] [Abstract][Full Text] [Related]
10. Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability.
Verma S; Goand UK; Husain A; Katekar RA; Garg R; Gayen JR
Drug Dev Res; 2021 Nov; 82(7):927-944. PubMed ID: 33988872
[TBL] [Abstract][Full Text] [Related]
11. Strategies and industrial perspectives to improve oral absorption of biological macromolecules.
Liu C; Kou Y; Zhang X; Cheng H; Chen X; Mao S
Expert Opin Drug Deliv; 2018 Mar; 15(3):223-233. PubMed ID: 29111841
[TBL] [Abstract][Full Text] [Related]
12. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
[TBL] [Abstract][Full Text] [Related]
13. Targeted oral peptide delivery using multi-unit particulates: Drug and permeation enhancer layering approach.
Tyagi P; Trivedi R; Pechenov S; Patel C; Revell J; Wills S; Huang Y; Rosenbaum AI; Subramony JA
J Control Release; 2021 Oct; 338():784-791. PubMed ID: 34499981
[TBL] [Abstract][Full Text] [Related]
14. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.
Brayden DJ; Hill TA; Fairlie DP; Maher S; Mrsny RJ
Adv Drug Deliv Rev; 2020; 157():2-36. PubMed ID: 32479930
[TBL] [Abstract][Full Text] [Related]
15. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery.
Leonaviciute G; Bernkop-Schnürch A
Expert Opin Drug Deliv; 2015; 12(11):1703-16. PubMed ID: 26477549
[TBL] [Abstract][Full Text] [Related]
16. An insight into gastrointestinal macromolecule delivery using physical oral devices.
Kaffash E; Shahbazi MA; Hatami H; Nokhodchi A
Drug Discov Today; 2022 Aug; 27(8):2309-2321. PubMed ID: 35460891
[TBL] [Abstract][Full Text] [Related]
17. Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability.
Tong T; Wang L; You X; Wu J
Biomater Sci; 2020 Nov; 8(21):5804-5823. PubMed ID: 33016274
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals.
Kim JC; Park EJ; Na DH
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559036
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Evaluation of 3D Printed Capsules with Pressure Triggered Release Mechanism for Oral Peptide Delivery.
Berg S; Krause J; Björkbom A; Walter K; Harun S; Granfeldt A; Janzén D; Nunes SF; Antonsson M; Van Zuydam N; Skrtic S; Hugerth A; Weitschies W; Davies N; Abrahamsson B; Bergström CAS
J Pharm Sci; 2021 Jan; 110(1):228-238. PubMed ID: 33212160
[TBL] [Abstract][Full Text] [Related]
20. Systems Biology and Peptide Engineering to Overcome Absorption Barriers for Oral Peptide Delivery: Dosage Form Optimization Case Study Preceding Clinical Translation.
Tyagi P; Patel C; Gibson K; MacDougall F; Pechenov SY; Will S; Revell J; Huang Y; Rosenbaum AI; Balic K; Maharoof U; Grimsby J; Subramony JA
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
